论文部分内容阅读
目的小儿毛细支气管炎应用氨溴特罗联合复方异丙托溴铵治疗的临床疗效。方法资料随机选自2012年7月~2014年7月本院诊治的毛细支气管炎患儿72例,随机分为对照组与研究组,两组各36例。对照组予以常规治疗,研究组在对照组基础上加用氨溴特罗联合复方异丙托溴铵,对比两组的临床疗效及症状改善情况。结果研究组的治疗显效率与总有效率均明显高于对照组差异具有统计学意义(P<0.05)。结论氨溴特罗联合复方异丙托溴铵治疗小儿毛细支气管炎效果显著。
Objective To evaluate the clinical efficacy of combining ambroxol and compound ipratropium bromide in children with bronchiolitis. Methods Data were randomly selected from 72 patients with bronchiolitis diagnosed and treated in our hospital from July 2012 to July 2014 and randomly divided into control group and study group, 36 cases in each group. The control group was given conventional treatment. The study group was given the combination of ambroxol and ibuprofen on the basis of the control group, and compared the clinical efficacy and symptom improvement. Results The effective rate and total effective rate of the treatment group were significantly higher than those of the control group (P <0.05). Conclusion The combination of ambroxol and compound ipratropium bromide is effective in treating bronchiolitis in children.